Researchers have developed a simple and cost-effective blood test capable of detecting Parkinson's disease long before symptoms emerge, comparing the current state of diagnosing neurodegenerative ...

Research led by Mirvie Inc. has discovered a molecular signal in blood samples that can predict preeclampsia and related ...

Investigators have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without causing unwanted mutations. The system can be formulated completely as ...

Renaissance BioScience Co-CEO John Husnik shares insight on the company’s yeast-based RNA-interference biopesticide ...

As previously reported, Wedbush initiated coverage of Wave Life Sciences (WVE) with an Outperform rating and $18 price target Wave stands out ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

AIR-001 is designed to restore functional alpha-1 antitrypsin (M-AAT) protein production by precisely repairing the SERPINA1 mutation (PiZ) to address the underlying cause of both lung and liver ...

AIRNA, a transatlantic RNA editing biotech, is prepping to launch its lead asset into clinical trials with fuel from a $155 ...

School of Public Health, Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, Southern Medical University, Guangzhou 510515, China ...

The discovery could pave the way for a groundbreaking RNA-based multi-cancer treatment. Alternative RNA splicing functions like a film editor rearranging scenes from the same footage to create ...

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will ...

Plus, news about Cen­tu­ry Ther­a­peu­tics, Ake­bia Ther­a­peu­tics, Eye­n­ovia, Be­taliq, Alvotech, Genen­ta Sci­ence, Aa­di Bio­science, and Ex­i­cure: ...